201
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Quinazoline clubbed thiazole and 1,3,4-oxadiazole heterocycles: synthesis, characterization, antibacterial evaluation, and molecular docking studies

ORCID Icon, , , &
Pages 569-577 | Received 21 Oct 2020, Accepted 01 Jan 2021, Published online: 21 Jan 2021

References

  • Majumdar, P.; Pati, A.; Patra, M.; Behera, R.; Behera, A. K. Acid Hydrazides, Potent Reagents for Synthesis of Oxygen-, Nitrogen-, and/or Sulfur-Containing Heterocyclic Rings. Chem. Rev. 2014, 114, 2942–2977. DOI: 10.1021/cr300122t.
  • Jansen, K. U.; Knirsch, C.; Anderson, A. S. The Role of Vaccines in Preventing Bacterial Antimicrobial Resistance. Nat. Med. 2018, 24, 10–19. DOI: 10.1038/nm.4465.
  • Li, X.; Ma, S. Advances in the Discovery of Novel Antimicrobials Targeting the Assembly of Bacterial Cell Division Protein FtsZ. Eur. J. Med. Chem. 2015, 95, 1–15. DOI: 10.1016/j.ejmech.2015.03.026.
  • Neeraja, P.; Srinivas, S.; Mukkanti, K.; Dubey, P. K.; Pal, S. 1H-1,2,3-Triazolyl-Substituted 1,3,4-Oxadiazole Derivatives Containing Structural Features of Ibuprofen/Naproxen: Their Synthesis and Antibacterial Evaluation. Bioorg. Med. Chem. Lett. 2016, 26, 5212–5217. DOI: 10.1016/j.bmcl.2016.09.059.
  • Singla, N.; Singh, G.; Bhatia, R.; Kumar, A.; Kaur, R.; Kaur, S. Design, Synthesis and Antimicrobial Evaluation of 1,3,4-Oxadiazole/1,2,4-Triazole-Substituted Thiophenes. ChemistrySelect 2020, 5, 3835–3842. DOI: 10.1002/slct.202000191.
  • Long, Q.; Liu, L.; Zhao, Y.; Wang, P.; Chen, B.; Li, Z.; Yang, S. Fabrication of Furan-Functionalized Quinazoline Hybrids: Their Antibacterial Evaluation, Quantitative Proteomics, and Induced Phytopathogen Morphological Variation Studies. J. Agric. Food Chem. 2019, 67, 11005–11017. DOI: 10.1021/acs.jafc.9b03419.
  • Desai, N. C.; Bhatt, N. B.; Joshi, S. B. Synthetic Modifications in Ethyl 2-Amino-4-Methylthiazole-5-Carboxylate: 3D QSAR Analysis and Antimicrobial Study. Synth. Commun. 2019, 49, 1055–1066. DOI: 10.1080/00397911.2019.1587777.
  • Shi, J.; Luo, N.; Ding, M.; Bao, X. Synthesis, In Vitro Antibacterial and Antifungal Evaluation of Novel 1,3,4-Oxadiazole Thioether Derivatives Bearing the 6-Fluoroquinazolinylpiperidinyl Moiety. Chin. Chem. Lett. 2020, 31, 434–438. DOI: 10.1016/j.cclet.2019.06.037.
  • Devipriya, D.; Roopan, S. M. UV-Light Intervened Synthesis of Imidazo Fused Quinazoline and Its Solvatochromism, Antioxidant, Antifungal and Luminescence Properties. J. Photochem. Photobiol. B Biol. 2019, 190, 42–49. DOI: 10.1016/j.jphotobiol.2018.11.003.
  • Sharma, P. C.; Bansal, K. K.; Sharma, A.; Sharma, D.; Deep, A. Thiazole-Containing Compounds as Therapeutic Targets for Cancer Therapy. Eur. J. Med. Chem. 2020, 188, 112016. DOI: 10.1016/j.ejmech.2019.112016.
  • Misra, A.; Dwivedi, J.; Shukla, S.; Kishore, D.; Sharma, S. Bacterial Cell Leakage Potential of Newly Synthesized Quinazoline Derivatives of 1,5-Benzodiazepines Analogue. J. Heterocycl. Chem. 2020, 57, 1545–1558. DOI: 10.1002/jhet.3879.
  • Bhati, S.; Kumar, V.; Singh, S.; Singh, J. Synthesis, Characterization, Antimicrobial, Anti-Tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(Pyridin-3-yl)-1Hbenzo[d]imidazole and 1,3,4-Oxadiazole Analogy. LDDD. 2020, 17, 1047–1059. DOI: 10.2174/1570180816666191122105313.
  • Desai, N. C.; Trivedi, A.; Somani, H.; Jadeja, K. A.; Vaja, D.; Nawale, L.; Khedkar, V. M.; Sarkar, D. Synthesis, Biological Evaluation, and Molecular Docking Study of Pyridine Clubbed 1,3,4-Oxadiazoles as Potential Antituberculars. Synth. Commun. 2018, 48, 524–540. DOI: 10.1080/00397911.2017.1410892.
  • Dutta, A.; Sarma, D. Recent Advances in the Synthesis of Quinazoline Analogues as Anti-TB Agents. Tuberculosis (Edinb) 2020, 124, 101986. DOI: 10.1016/j.tube.2020.101986.
  • Bekhit, A. A.; Saudi, M. N.; Hassan, A. M. M.; Fahmy, S. M.; Ibrahim, T. M.; Ghareeb, D.; El-Seidy, A. M.; Nasralla, S. N. A.; Bekhit, A. E. Synthesis, In Silico Experiments and Biological Evaluation of 1,3,4-Trisubstituted Pyrazole Derivatives as Antimalarial Agents. Eur. J. Med. Chem. 2019, 163, 353–366. DOI: 10.1016/j.ejmech.2018.11.067.
  • Abd-Ellah, H. S.; Abdel-Aziz, M.; Shoman, M. E.; Beshr, E. A. M.; Kaoud, T. S.; Ahmed, A. F. F. Novel 1,3,4-Oxadiazole/Oxime Hybrids: Synthesis, Docking Studies and Investigation of Anti-Inflammatory, Ulcerogenic Liability and Analgesic Activities. Bioorg. Chem. 2016, 69, 48–63. DOI: 10.1016/j.bioorg.2016.09.005.
  • Mishchenko, M.; Shtrygol, S.; Kaminskyy, D.; Lesyk, R. Thiazole-Bearing 4-Thiazolidinones as New Anticonvulsant Agents. Sci. Pharm. 2020, 88, 16. DOI: 10.3390/scipharm88010016.
  • Maghraby, M. T.-E.; Abou-Ghadir, O. M. F.; Abdel-Moty, S. G.; Ali, A. Y.; Salem, O. I. A. Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes. Bioorg. Med. Chem. 2020, 28, 115403. DOI: 10.1016/j.bmc.2020.115403.
  • Asma, Kalluraya, B.; Manju, N.; Sharath, C.; L. Synthesis and Antioxidant Activity Study of Carbothioamide and Their Corresponding Thiazole Derivatives. J. Heterocycl. Chem. 2020, 57, 3105–3115. DOI: 10.1002/jhet.4018.
  • Desai, N. C.; Joshi, V. V.; Rajpara, K. M.; Makwana, A. H. A New Synthetic Approach and In Vitro Antimicrobial Evaluation of Novel Imidazole Incorporated 4-Thiazolidinone Motifs. Arab. J. Chem. 2017, 10, S589–S599. DOI: 10.1016/j.arabjc.2012.10.020.
  • Chandrakantha, B.; Shetty, P.; Nambiyar, V.; Isloor, N.; Isloor, A. M. Synthesis, Characterization and Biological Activity of Some New 1,3,4-Oxadiazole Bearing 2-Flouro-4-Methoxy Phenyl Moiety. Eur. J. Med. Chem. 2010, 45, 1206–1210. DOI: 10.1016/j.ejmech.2009.11.046.
  • Zheng, Z.; Liu, Q.; Kim, W.; Tharmalingam, N.; Fuchs, B. B.; Mylonakis, E. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives against Planktonic Cells and Biofilm of Staphylococcus aureus. Future Med. Chem. 2018, 10, 283–296. DOI: 10.4155/fmc-2017-0159.
  • Torre, B. G.; Albericio, F. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 2019, 24, 809. DOI: 10.3390/molecules24040809.
  • Desai, N. C.; Bhatt, N.; Somani, H.; Trivedi, A. Synthesis, Antimicrobial and Cytotoxic Activities of Some Novel Thiazole Clubbed 1,3,4-Oxadiazoles. Eur. J. Med. Chem. 2013, 67, 54–59. DOI: 10.1016/j.ejmech.2013.06.029.
  • Du, H.; Ding, M.; Luo, N.; Shi, J.; Huang, J.; Bao, X. Design, Synthesis, Crystal Structure and in Vitro Antimicrobial Activity of Novel 1,2,4-Triazolo[1,5-a]pyrimidine-Containing Quinazolinone Derivatives. Mol. Divers 2020, 1–12. DOI: 10.1007/s11030-020-10043-z.
  • Desai, N. C.; Karkar, T. J.; Vekariya, R. H.; Joshi, S. B.; Jadeja, K. A.; Vaja, D. V. Synthesis, Characterization, Molecular Docking Studies and Biological Activity of Coumarin Linked 2-Pyridone Heterocycles. Indian J. Chem. 2020, 59B, 231–237. DOI: http://nopr.niscair.res.in/handle/123456789/54002.
  • Desai, N. C.; Patel, B. Y.; Dave, B. P. Synthesis and Antimicrobial Activity of Novel Quinoline Derivatives Bearing Pyrazoline and Pyridine Analogues. Med. Chem. Res. 2017, 26, 109–119. DOI: 10.1007/s00044-016-1732-6.
  • Kumar, R. A.; Maheswari, C. U.; Ghantasala, S.; Jyothi, C.; Reddy, K. R. Synthesis of 3H-Quinazolin-4-Ones and 4H-3,1-Benzoxazin-4-Ones via Benzylic Oxidation and Oxidative Dehydrogenation Using Potassium Iodide-Tert-Butyl Hydroperoxide. Adv. Synth. Catal. 2011, 353, 401–410. DOI: 10.1002/adsc.201000580.
  • Pommier, Y. Drugging Topoisomerases: Lessons and Challenges. ACS Chem. Biol. 2013, 8, 82–95. DOI: 10.1021/cb300648v.
  • Ehmann, D. E.; Lahiri, S. D. Novel Compounds Targeting Bacterial DNA Topoisomerase/DNA Gyrase. Curr. Opin. Pharmacol. 2014, 18, 76–83. DOI: 10.1016/j.coph.2014.09.007.
  • Maxwell, A.; Lawson, D. M. The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs. Curr. Top. Med. Chem. 2003, 3, 283–303. DOI: 10.2174/1568026033452500.
  • Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes. J. Med. Chem. 2006, 49, 6177–6196. DOI: 10.1021/jm051256o.
  • Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 2004, 47, 1739–1749. DOI: 10.1021/jm0306430.
  • Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye, L. L.; Pollard, W. T.; Banks, J. L. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J. Med. Chem. 2004, 47, 1750–1759. DOI: 10.1021/jm030644s.
  • Phatak, P. S.; Sathe, B. P.; Dhumal, S. T.; Rehman, N. N. M. A.; Dixit, P. P.; Khedkar, V. M.; Haval, K. P. Synthesis, Antimicrobial Evaluation, and Docking Studies of Substituted Acetylphenoxymethyl-Triazolyl-N-Phenylacetamides. J. Heterocycl. Chem. 2019, 56, 1928–1938. DOI: 10.1002/jhet.3568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.